Pietro Vernassa - Search Results

Year	Number of Results
1997	1
2002	6
2003	9
2004	10
2005	10
2006	4
2007	12
2008	13
2009	9
2010	15
2011	17
2012	9
2013	12
2014	9
2015	9
2016	11
2017	4
2018	2
2019	8
2020	18
2021	6

1

Author Correction: The influence of human genetic variation on Epstein-Barr virus sequence diversity.

Rüeger S, Hammer C, Loetscher A, McLaren PJ, Lawless D, Naret O, Khanna N, Bernasconi E, Cavassini M, Günthard HF, Kahlert CR, Rauch A, Depledge DP, Morfopoulou S, Breuer J, Zdobnov E, Fellay J; Swiss HIV Cohort Study. Rüeger S, et al. Sci Rep. 2021 Apr 20;11(1):8946. doi: 10.1038/s41598-021-87274-z. Sci Rep. 2021. PMID: 33879823 Free PMC article. No abstract available.

2

Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.

Courlet P, Barbieux C, Sculier D, Wandeler G, Stoeckle M, Bernasconi E, Braun D, Vernazza P, Cavassini M, Marinosci A, Smit M, Günthard HF, Schmid P, Limacher A, Guidi M, Alves Saldanha S, Decosterd LA, Calmy A. Courlet P, et al. Among authors: vernazza p. Br J Clin Pharmacol. 2021 Mar 25. doi: 10.1111/bcp.14832. Online ahead of print. Br J Clin Pharmacol. 2021. PMID: 33764567

3

Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study.

Sieber P, Flury D, Güsewell S, Albrich WC, Boggian K, Gardiol C, Schlegel M, Sieber R, Vernazza P, Kohler P. Sieber P, et al. Among authors: vernazza p. BMC Infect Dis. 2021 Mar 17;21(1):271. doi: 10.1186/s12879-021-05957-4. BMC Infect Dis. 2021. PMID: 33731019 Free PMC article.

4

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.

Bregenzer A, Bruggmann P, Castro E, Moriggia A, Rothen M, Thurnheer MC, Vernazza P, Scheidegger C. Bregenzer A, et al. Among authors: vernazza p. Swiss Med Wkly. 2021 Mar 4;151:w20460. doi: 10.4414/smw.2021.20460. eCollection 2021 Mar 1. Swiss Med Wkly. 2021. PMID: 33705563 Free article.

5

The influence of human genetic variation on Epstein-Barr virus sequence diversity.

Rüeger S, Hammer C, Loetscher A, McLaren PJ, Lawless D, Naret O, Khanna N, Bernasconi E, Cavassini M, Günthard HF, Kahlert CR, Rauch A, Depledge DP, Morfopoulou S, Breuer J, Zdobnov E, Fellay J; Swiss HIV Cohort Study. Rüeger S, et al. Sci Rep. 2021 Feb 25;11(1):4586. doi: 10.1038/s41598-021-84070-7. Sci Rep. 2021. PMID: 33633271 Free PMC article.

6

Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies.

Weber MC, Risch M, Thiel SL, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Egli K, Bodmer T, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Kahlert CR. Weber MC, et al. Among authors: vernazza p. Dis Markers. 2021 Jan 6;2021:8810196. doi: 10.1155/2021/8810196. eCollection 2021. Dis Markers. 2021. PMID: 33532006 Free PMC article.

7

The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men.

Schmidt AJ, Rasi M, Esson C, Christinet V, Ritzler M, Lung T, Hauser CV, Stöckle M, Jouinot F, Lehner A, Lange K, Konrad T, Vernazza PL. Schmidt AJ, et al. Among authors: vernazza pl. Swiss Med Wkly. 2020 Dec 31;150:w20392. doi: 10.4414/smw.2020.20392. eCollection 2020 Dec 14. Swiss Med Wkly. 2020. PMID: 33382077 Free article.

8

The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women.

Vernazza PL, Rasi M, Ritzler M, Dost F, Stoffel M, Aebi-Popp K, Hauser CV, Esson C, Lange K, Risch L, Schmidt AJ. Vernazza PL, et al. Swiss Med Wkly. 2020 Dec 31;150:w20393. doi: 10.4414/smw.2020.20393. eCollection 2020 Dec 14. Swiss Med Wkly. 2020. PMID: 33382076 Free article.

9

Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.

Schaffner A, Risch L, Aeschbacher S, Risch C, Weber MC, Thiel SL, Jüngert K, Pichler M, Grossmann K, Wohlwend N, Lung T, Hillmann D, Bigler S, Bodmer T, Imperiali M, Renz H, Kohler P, Vernazza P, Kahlert CR, Twerenbold R, Paprotny M, Conen D, Risch M. Schaffner A, et al. Among authors: vernazza p. J Clin Med. 2020 Dec 9;9(12):3989. doi: 10.3390/jcm9123989. J Clin Med. 2020. PMID: 33317059 Free PMC article.

10

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.

Kusejko K, Günthard HF, Olson GS, Zens K, Darling K, Khanna N, Furrer H, Vetter P, Bernasconi E, Vernazza P, Hoffmann M, Kouyos RD, Nemeth J; Swiss HIV Cohort Study. Kusejko K, et al. Among authors: vernazza p. PLoS Biol. 2020 Dec 7;18(12):e3000963. doi: 10.1371/journal.pbio.3000963. eCollection 2020 Dec. PLoS Biol. 2020. PMID: 33284802 Free PMC article.

11

Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.

Risch M, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Egli K, Bodmer T, Imperiali M, Salimi Y, Fleisch F, Cusini A, Renz H, Kohler P, Vernazza P, Kahlert CR, Paprotny M, Risch L. Risch M, et al. Among authors: vernazza p. Biomed Res Int. 2020 Nov 16;2020:9878453. doi: 10.1155/2020/9878453. eCollection 2020. Biomed Res Int. 2020. PMID: 33224987 Free PMC article.

12

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.

Sculier D, Wandeler G, Yerly S, Marinosci A, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd LA, Günthard HF, Schmid P, Limacher A, Egger M, Calmy A; Swiss HIV Cohort Study (SHCS). Sculier D, et al. Among authors: vernazza p. PLoS Med. 2020 Nov 10;17(11):e1003421. doi: 10.1371/journal.pmed.1003421. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33170863 Free PMC article. Clinical Trial.

13

HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.

Carlisle LA, Turk T, Metzner KJ, Mbunkah HA, Shah C, Böni J, Huber M, Braun DL, Fehr J, Salazar-Vizcaya L, Rauch A, Yerly S, Nguyen A, Cavassini M, Stoeckle M, Vernazza P, Bernasconi E, Günthard HF, Kouyos RD. Carlisle LA, et al. Among authors: vernazza p. Viruses. 2020 Oct 31;12(11):1241. doi: 10.3390/v12111241. Viruses. 2020. PMID: 33142675 Free PMC article.

14

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.

Wan C, Bachmann N, Mitov V, Blanquart F, Céspedes SP, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Fellay J, Roth V, Böni J, Perreau M, Klimkait T, Yerly S, Battegay M, Walti L, Calmy A, Vernazza P, Bernasconi E, Cavassini M, Metzner KJ, Günthard HF, Kouyos RD; Swiss HIV Cohort Study. Wan C, et al. Among authors: vernazza p. Nat Commun. 2020 Nov 2;11(1):5542. doi: 10.1038/s41467-020-19198-7. Nat Commun. 2020. PMID: 33139735 Free PMC article.

15

Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study.

Thiel SL, Weber MC, Risch L, Wohlwend N, Lung T, Hillmann D, Ritzler M, Risch M, Kohler P, Vernazza P, Kahlert CR, Fleisch F, Cusini A, Karajan TV, Copeland S, Paprotny M. Thiel SL, et al. Among authors: vernazza p. Swiss Med Wkly. 2020 Oct 16;150:w20361. doi: 10.4414/smw.2020.20361. eCollection 2020 Oct 5. Swiss Med Wkly. 2020. PMID: 33105020 Free article.

16

Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment.

Pyngottu A, Scherrer AU, Kouyos R, Huber M, Hirsch H, Perreau M, Yerly S, Calmy A, Cavassini M, Stöckle M, Furrer H, Vernazza P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study. Pyngottu A, et al. Among authors: vernazza p. Clin Infect Dis. 2020 Oct 24:ciaa1614. doi: 10.1093/cid/ciaa1614. Online ahead of print. Clin Infect Dis. 2020. PMID: 33095848 Free article.

17

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study.

Kohler PP, Kahlert CR, Sumer J, Flury D, Güsewell S, Leal-Neto OB, Notter J, Albrich WC, Babouee Flury B, McGeer A, Kuster S, Risch L, Schlegel M, Vernazza P. Kohler PP, et al. Among authors: vernazza p. Infect Control Hosp Epidemiol. 2020 Oct 8:1-5. doi: 10.1017/ice.2020.1244. Online ahead of print. Infect Control Hosp Epidemiol. 2020. PMID: 33028454 Free PMC article.

18

Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.

Hasan Ali O, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, Thiel S, Kern L, Albrich WC, Kohler P, Kahlert CR, Vernazza P, Bühler PK, Schüpbach RA, Gómez-Mejia A, Popa AM, Bergthaler A, Penninger JM, Flatz L. Hasan Ali O, et al. Among authors: vernazza p. Clin Infect Dis. 2020 Sep 30:ciaa1496. doi: 10.1093/cid/ciaa1496. Online ahead of print. Clin Infect Dis. 2020. PMID: 32997739 Free PMC article.

19

Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study.

Baron RC, Risch L, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Egli K, Ferrara F, Bodmer T, Imperiali M, Heer S, Renz H, Flatz L, Kohler P, Vernazza P, Kahlert CR, Paprotny M, Risch M. Baron RC, et al. Among authors: vernazza p. Clin Chem Lab Med. 2020 Aug 31;58(12):2131-2140. doi: 10.1515/cclm-2020-0978. Clin Chem Lab Med. 2020. PMID: 32866113

20

EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA).

Kovac M, Risch L, Thiel S, Weber M, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Ferrara F, Bodmer T, Egli K, Imperiali M, Heer S, Salimi Y, Renz H, Kohler P, Vernazza P, Kahlert CR, Paprotny M, Risch M. Kovac M, et al. Among authors: vernazza p. Diagnostics (Basel). 2020 Aug 14;10(8):593. doi: 10.3390/diagnostics10080593. Diagnostics (Basel). 2020. PMID: 32823852 Free PMC article.

21

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.

Esposito I, Cicconi P, D'Alise AM, Brown A, Esposito M, Swadling L, Holst PJ, Bassi MR, Stornaiuolo M, Mori F, Vassilev V, Li W, Donnison T, Gentile C, Turner B, von Delft A, Del Sorbo M, Barra F, Contino AM, Abbate A, Novellino E, Thomsen AR, Christensen JP, Lahm A, Grazioli F, Ammendola V, Siani L, Colloca S, Klenerman P, Nicosia A, Dorrell L, Folgori A, Capone S, Barnes E; PEACHI Consortium. Esposito I, et al. Sci Transl Med. 2020 Jun 17;12(548):eaaz7715. doi: 10.1126/scitranslmed.aaz7715. Sci Transl Med. 2020. PMID: 32554708

22

Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of HIV Transmission in MSM.

Bachmann N, Kusejko K, Nguyen H, Chaudron SE, Kadelka C, Turk T, Böni J, Perreau M, Klimkait T, Yerly S, Battegay M, Rauch A, Ramette A, Vernazza P, Bernasconi E, Cavassini M, Günthard HF, Kouyos RD; Swiss HIV Cohort Study. Bachmann N, et al. Among authors: vernazza p. Clin Infect Dis. 2020 Apr 17:ciaa411. doi: 10.1093/cid/ciaa411. Online ahead of print. Clin Infect Dis. 2020. PMID: 32300807

23

Polymorphisms of SOCS-1 Are Associated With a Rapid HIV Progression Rate.

Hersberger M, Schlaepfer E, Buehler M, Bochud PY, Vernazza P, Marti-Jaun J, Nemeth J, Zwahlen M, Schmidlin K, Speck RF; Swiss HIV Cohort Study. Hersberger M, et al. Among authors: vernazza p. J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):189-195. doi: 10.1097/QAI.0000000000002319. J Acquir Immune Defic Syndr. 2020. PMID: 32097250

24

Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity.

Roth JA, Franzeck FC, Balakrishna S, Lautenschlager S, Thurnheer MC, Trellu LT, Cavassini M, Vernazza P, Bernasconi E, Braun D, Kouyos RD, Battegay M; Swiss HIV Cohort Study (SHCS). Roth JA, et al. Among authors: vernazza p. Open Forum Infect Dis. 2020 Jan 12;7(1):ofaa019. doi: 10.1093/ofid/ofaa019. eCollection 2020 Jan. Open Forum Infect Dis. 2020. PMID: 32016128 Free PMC article.

25

Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.

Ruffieux Y, Lemsalu L, Aebi-Popp K, Calmy A, Cavassini M, Fux CA, Günthard HF, Marzolini C, Scherrer A, Vernazza P, Keiser O, Egger M; Swiss HIV Cohort Study and the Swiss National Cohort. Ruffieux Y, et al. Among authors: vernazza p. J Int AIDS Soc. 2019 Aug;22(8):e25339. doi: 10.1002/jia2.25339. J Int AIDS Soc. 2019. PMID: 31423727 Free PMC article.

26

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

Bachmann N, von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Fellay J, Roth V, Kok YL, Thorball CW, Borghesi A, Parbhoo S, Wieser M, Böni J, Perreau M, Klimkait T, Yerly S, Battegay M, Rauch A, Hoffmann M, Bernasconi E, Cavassini M, Kouyos RD, Günthard HF, Metzner KJ; Swiss HIV Cohort Study. Bachmann N, et al. Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9. Nat Commun. 2019. PMID: 31324762 Free PMC article.

27

HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected.

Nguyen H, Thorball CW, Fellay J, Böni J, Yerly S, Perreau M, Klimkait T, Kusejko K, Bachmann N, Chaudron SE, Paioni P, Thurnheer MC, Battegay M, Cavassini M, Vernazza P, Bernasconi E, Günthard HF, Kouyos R; Swiss HIV Cohort Study. Nguyen H, et al. Among authors: vernazza p. J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):508-515. doi: 10.1097/QAI.0000000000002077. J Acquir Immune Defic Syndr. 2019. PMID: 31107301 Free article.

28

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: vernazza p. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.

29

Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?

Notter J, Bregenzer A, Vernazza P, Kahlert CR. Notter J, et al. Among authors: vernazza p. Swiss Med Wkly. 2019 Apr 24;149:w20053. doi: 10.4414/smw.2019.20053. eCollection 2019 Apr 22. Swiss Med Wkly. 2019. PMID: 31017649 Free article.

30

The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.

Young J, Scherrer AU, Calmy A, Tarr PE, Bernasconi E, Cavassini M, Hachfeld A, Vernazza P, Günthard HF, Bucher HC; Swiss HIV Cohort Study. Young J, et al. Among authors: vernazza p. Antivir Ther. 2019;24(5):343-353. doi: 10.3851/IMP3310. Antivir Ther. 2019. PMID: 30985290

31

Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection.

Carlisle LA, Turk T, Kusejko K, Metzner KJ, Leemann C, Schenkel CD, Bachmann N, Posada S, Beerenwinkel N, Böni J, Yerly S, Klimkait T, Perreau M, Braun DL, Rauch A, Calmy A, Cavassini M, Battegay M, Vernazza P, Bernasconi E, Günthard HF, Kouyos RD; Swiss HIV Cohort Study. Carlisle LA, et al. Among authors: vernazza p. J Infect Dis. 2019 Jun 19;220(2):254-265. doi: 10.1093/infdis/jiz094. J Infect Dis. 2019. PMID: 30835266

32

Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.

Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Müllhaupt B, Negro F, Semela D. Rusch U, et al. Among authors: vernazza p. Swiss Med Wkly. 2019 Jan 23;149:w14694. doi: 10.4414/smw.2019.14694. eCollection 2019 Jan 14. Swiss Med Wkly. 2019. PMID: 30673118 Free article.

33

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.

Kouyos RD, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, Schanz M, Liechti T, Friedrich N, Braun DL, Scherrer AU, Weber J, Uhr T, Baumann NS, Leemann C, Kuster H, Chave JP, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Metzner KJ, Günthard HF, Trkola A; Swiss HIV Cohort Study. Kouyos RD, et al. Nature. 2018 Sep;561(7723):406-410. doi: 10.1038/s41586-018-0517-0. Epub 2018 Sep 10. Nature. 2018. PMID: 30202088

34

Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?

Kahlert C, Aebi-Popp K, Bernasconi E, Martinez de Tejada B, Nadal D, Paioni P, Rudin C, Staehelin C, Wagner N, Vernazza P. Kahlert C, et al. Among authors: vernazza p. Swiss Med Wkly. 2018 Jul 24;148:w14648. doi: 10.4414/smw.2018.14648. eCollection 2018. Swiss Med Wkly. 2018. PMID: 30044473 Free article.

35

Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study.

Mayer LM, Kahlert C, Rassouli F, Vernazza P, Albrich WC. Mayer LM, et al. Among authors: vernazza p. Pneumonia (Nathan). 2017 Feb 25;9:4. doi: 10.1186/s41479-017-0028-z. eCollection 2017. Pneumonia (Nathan). 2017. PMID: 28702306 Free PMC article.

36

Adverse events of raltegravir and dolutegravir.

Elzi L, Erb S, Furrer H, Cavassini M, Calmy A, Vernazza P, Günthard H, Bernasconi E, Battegay M; Swiss HIV Cohort Study Group. Elzi L, et al. Among authors: vernazza p. AIDS. 2017 Aug 24;31(13):1853-1858. doi: 10.1097/QAD.0000000000001590. AIDS. 2017. PMID: 28692533 Free PMC article.

37

Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades.

Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Levi J, et al. Among authors: vernazza p. BMJ Glob Health. 2016 Sep 15;1(2):e000010. doi: 10.1136/bmjgh-2015-000010. eCollection 2016. BMJ Glob Health. 2016. PMID: 28588933 Free PMC article.

38

Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial.

Carreño JM, Perez-Shibayama C, Gil-Cruz C, Lopez-Macias C, Vernazza P, Ludewig B, Albrich WC. Carreño JM, et al. Among authors: vernazza p. PLoS One. 2017 Jun 1;12(6):e0178669. doi: 10.1371/journal.pone.0178669. eCollection 2017. PLoS One. 2017. PMID: 28570603 Free PMC article. Clinical Trial.

39

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

Gueler A, Moser A, Calmy A, Günthard HF, Bernasconi E, Furrer H, Fux CA, Battegay M, Cavassini M, Vernazza P, Zwahlen M, Egger M; Swiss HIV Cohort Study, Swiss National Cohort. Gueler A, et al. Among authors: vernazza p. AIDS. 2017 Jan 28;31(3):427-436. doi: 10.1097/QAD.0000000000001335. AIDS. 2017. PMID: 27831953 Free PMC article.

40

Determinants of HIV-1 broadly neutralizing antibody induction.

Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, Huber M, Braun DL, Hozé N, Scherrer A, Magnus C, Weber J, Uhr T, Cippa V, Thorball CW, Kuster H, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Fellay J, Regoes RR, Günthard HF, Trkola A; Swiss HIV Cohort Study. Rusert P, et al. Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187. Epub 2016 Sep 26. Nat Med. 2016. PMID: 27668936

41

Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

Salazar-Vizcaya L, Kouyos RD, Zahnd C, Wandeler G, Battegay M, Darling KE, Bernasconi E, Calmy A, Vernazza P, Furrer H, Egger M, Keiser O, Rauch A; Swiss HIV Cohort Study. Salazar-Vizcaya L, et al. Among authors: vernazza p. Hepatology. 2016 Dec;64(6):1856-1869. doi: 10.1002/hep.28769. Epub 2016 Oct 19. Hepatology. 2016. PMID: 27531615 Free PMC article.

42

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: vernazza p. JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148. JAMA. 2016. PMID: 27404185 Free article.

43

Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.

Shilaih M, Marzel A, Yang WL, Scherrer AU, Schüpbach J, Böni J, Yerly S, Hirsch HH, Aubert V, Cavassini M, Klimkait T, Vernazza PL, Bernasconi E, Furrer H, Günthard HF, Kouyos R; Swiss HIV Cohort Study. Shilaih M, et al. Among authors: vernazza pl. Sci Rep. 2016 Jun 14;6:27580. doi: 10.1038/srep27580. Sci Rep. 2016. PMID: 27297284 Free PMC article.

44

[Influenza – Not innocuous, but preventable].

Vernazza P. Vernazza P. Ther Umsch. 2016;73(5):231-4. doi: 10.1024/0040-5930/a000784. Ther Umsch. 2016. PMID: 27268444 Review. German.

45

Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.

Scherrer AU, von Wyl V, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Furrer H, Calmy A, Vernazza P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rudin C, Schöni-Affolter F, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Weber R, Yerly S. Scherrer AU, et al. Among authors: vernazza p. Clin Infect Dis. 2016 May 15;62(10):1310-1317. doi: 10.1093/cid/ciw128. Epub 2016 Mar 8. Clin Infect Dis. 2016. PMID: 26962075

46

HIV screening: better communication instead of searching for a needle in a haystack?

Vernazza PL. Vernazza PL. Swiss Med Wkly. 2016 Jan 31;146:w14224. doi: 10.4414/smw.2016.14224. eCollection 2016. Swiss Med Wkly. 2016. PMID: 26827370 Free article. No abstract available.

47

HIV is not transmitted under fully suppressive therapy: The Swiss Statement--eight years later.

Vernazza P, Bernard EJ. Vernazza P, et al. Swiss Med Wkly. 2016 Jan 29;146:w14246. doi: 10.4414/smw.2016.14246. eCollection 2016. Swiss Med Wkly. 2016. PMID: 26824882 Free article. No abstract available.

48

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Aouri M, Barcelo C, Ternon B, Cavassini M, Anagnostopoulos A, Yerly S, Hugues H, Vernazza P, Günthard HF, Buclin T, Telenti A, Rotger M, Decosterd LA; Swiss HIV Cohort Study. Aouri M, et al. Among authors: vernazza p. Drug Metab Dispos. 2016 Jan;44(1):151-61. doi: 10.1124/dmd.115.065839. Epub 2015 Nov 9. Drug Metab Dispos. 2016. PMID: 26553012

49

Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.

Schmid P, Bregenzer A, Huber M, Rauch A, Jochum W, Müllhaupt B, Vernazza P, Opravil M, Weber R; Swiss HIV Cohort Study. Schmid P, et al. Among authors: vernazza p. PLoS One. 2015 Sep 29;10(9):e0138838. doi: 10.1371/journal.pone.0138838. eCollection 2015. PLoS One. 2015. PMID: 26418061 Free PMC article.

50

HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study.

Marzel A, Shilaih M, Yang WL, Böni J, Yerly S, Klimkait T, Aubert V, Braun DL, Calmy A, Furrer H, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Günthard HF, Kouyos RD; Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard HF, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari H, Ledergerber B, Martinetti G, de Tejada BM, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid P, Schüpbach J, Speck R, Tarr P, Trkola A, Vernazza PL, Weber R, Yerly S. Marzel A, et al. Among authors: vernazza pl. Clin Infect Dis. 2016 Jan 1;62(1):115-122. doi: 10.1093/cid/civ732. Epub 2015 Sep 19. Clin Infect Dis. 2016. PMID: 26387084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results